Puberty Blockers Raise Concerns, FDA Warnings

The FDA has added a new warning to the labeling of puberty blockers. It now warns of symptoms such as headaches, nausea, and vision loss. A researcher with the Heritage Foundation has found a correlation between increased suicide rates among young people and states that allow minors access to cross-sex medications without parental consent.